In 2000, Bayer Healthcare introduced the Mirena IUD, which is a flexible T-shaped RUD implant that is placed in the uterus for up to five years as a form of birth control. It has been a relatively effective birth control device. It is even more effective in preventing pregnancy than even female sterilization. But while effective for its intended purpose, a lot of problems have been reported with the Mirena IUD. Since 2004, the FDA has received over 77,000 adverse event reports relating to Mirena.
Mirena IUD’s have been linked to perforating uteri, and the IUD’s have been known to move out of position on occasion, causing internal injuries, with over 4,000 lawsuits pending from women. The reality is these cases have either failing or have already failed. It is unfair but our justice system is not always fair. Recently, however, a new type of lawsuit has started to arise regarding Mirena IUD’s and Bayer Healthcare Pharmaceuticals.
PTC is called many different things: idiopathic intracranial hypertension, pseudotumor cerebri, benign intracranial hypertension are the most common. This serious condition is characterized by a buildup of fluid pressure on the brain. This fluid buildup results in severe headaches, vision loss, and possibly other problems.
PTC is most commonly in obese females of reproductive age. The biggest symptom of PTC is papilledema. Early symptoms include headaches and visual disturbances. Patients with these symptoms, particularly obese patients or those with recent weight gain, should be screened for papilledema and, if present, the patient should be referred to a neurologist for further diagnosis and care. Continue reading